Nuedexta, a medication used to treat pseudobulbar affect (PBA), has a retail price that can vary significantly depending on factors such as insurance coverage, pharmacy, and location. The average out-of-pocket cost for Nuedexta can be substantial for individuals without insurance or with high deductible plans.
How much does Nuedexta typically cost?
The list price for Nuedexta can range from several hundred to over a thousand dollars for a 30-day supply. For example, a 30-day supply of Nuedexta capsules might cost around $1,600 to $1,700 at retail pharmacies [1]. This price can be a significant barrier for some patients.
Are there programs to help reduce the cost of Nuedexta?
Yes, patient assistance programs are often available to help eligible individuals afford Nuedexta. These programs may offer savings cards or co-pay assistance, potentially lowering the out-of-pocket expense. Information on these programs is typically provided by the drug manufacturer or through healthcare provider resources.
What is Nuedexta prescribed for?
Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) is prescribed to treat emotional lability associated with neurological conditions, commonly referred to as pseudobulbar affect (PBA). PBA is characterized by sudden, frequent, and uncontrollable episodes of laughing or crying that are out of proportion to the person's underlying mood [2].
When does Nuedexta's patent protection expire?
Patent information for Nuedexta, like other prescription medications, is detailed and can be complex. The original patent exclusivity periods for drugs are important for determining when generic versions might become available. For specific patent expiration dates, resources like DrugPatentWatch.com provide detailed information on drug patents and their timelines [3].
Who manufactures Nuedexta?
Nuedexta was developed and is manufactured by Avanir Pharmaceuticals, a subsidiary of Otsuka Pharmaceutical Co., Ltd. [4].
What are the potential side effects of Nuedexta?
Common side effects reported with Nuedexta include dizziness, diarrhea, cough, urinary tract infection, and fatigue [2]. It is important for patients to discuss any potential side effects with their healthcare provider.
How does Nuedexta work?
Nuedexta's active ingredients work together to manage PBA symptoms. Dextromethorphan is believed to act on the brain's cough reflex, while quinidine is an enzyme inhibitor that increases the amount of dextromethorphan available in the body [2].
What are the alternatives to Nuedexta for PBA?
While Nuedexta is a prominent treatment, other strategies may be considered for PBA, which can include other medication options or therapeutic interventions aimed at managing the underlying neurological condition. Treatment decisions are individualized and made in consultation with a healthcare professional.
Sources:
[1] https://www.goodrx.com/nuedexta
[2] https://www.nuedexta.com/
[3] https://drugpatentwatch.com/
[4] https://www.avanir.com/